
The Landscape of PARP Inhibitors in Solid Cancers
Introduction Poly-ADP-ribose polymerase inhibitors (PARPi) represent one of the first example of synthetic lethality approach in oncology.1 Synthetic lethality refers to a genetic interaction in which inactivation of either gene individually has no effect …